Seer, Inc. (SEER)
NASDAQ: SEER · Real-Time Price · USD
1.720
-0.030 (-1.71%)
At close: May 15, 2026, 4:00 PM EDT
1.750
+0.030 (1.74%)
After-hours: May 15, 2026, 4:47 PM EDT
Seer, Inc. Market Cap
Seer, Inc. has a market cap or net worth of $97.04 million as of May 15, 2026. Its market cap has decreased by -22.25% in one year.
Market Cap
97.04M
Enterprise Value
-46.60M
1-Year Change
-22.25%
Ranking
Category
Stock Price
$1.72
Market Cap Chart
Since the IPO on December 4, 2020, Seer, Inc.'s market cap has decreased from $1.12B to $97.04M, a decrease of -91.32%. That is a compound annual growth rate of -36.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 96.31M | -6.54% |
| Dec 31, 2025 | 103.05M | -27.09% |
| Dec 31, 2024 | 141.34M | 13.56% |
| Dec 29, 2023 | 124.46M | -65.83% |
| Dec 30, 2022 | 364.27M | -74.24% |
| Dec 31, 2021 | 1.41B | 26.55% |
| Dec 4, 2020 | 1.12B | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cognition Therapeutics | 101.86M |
| Aldeyra Therapeutics | 101.34M |
| Vivani Medical | 100.90M |
| Cibus | 99.93M |
| Aardvark Therapeutics | 99.70M |
| Oncolytics Biotech | 98.71M |
| Biomea Fusion | 97.60M |
| Anixa Biosciences | 94.55M |